DCM
QTTB icon

Dimension Capital Management’s Q32 Bio QTTB Stock Holding History

Dimension Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-608
Closed -$6.66K – 124
2023
Q4 		$6.66K Hold
608
– – ﹤0.01% 110
2023
Q3 		$12.8K Hold
608
– – ﹤0.01% 91
2023
Q2 		$9.69K Sell
608
-281
-32% -$5.04K ﹤0.01% 100
2023
Q1 		$16.5K Hold
889
– – ﹤0.01% 105
2022
Q4 		$20.2K Hold
889
– – ﹤0.01% 105
2022
Q3 		$26K Hold
889
– – 0.01% 99
2022
Q2 		$32K Hold
889
– – 0.01% 100
2022
Q1 		$49K Buy
889
+278
+45% +$17.3K 0.01% 108
2021
Q4 		$40K Buy
+611
New +$59.3K 0.01% 102

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimension Capital Management's QTTB Position: Q1 2024 in Review

Dimension Capital Management sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 608 shares — an estimated $6.66K sold.

Dimension Capital Management first reported a position in QTTB in Q4 2021 and held it in 9 quarters. The position peaked at $49K in Q1 2022. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • Dimension Capital Management reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • Dimension Capital Management sold 608 Q32 Bio shares in Q1 2024, an estimated $6.66K.
  • Dimension Capital Management first reported a position in Q32 Bio in Q4 2021 and held it in 9 quarters.
  • Dimension Capital Management's Q32 Bio position peaked at $49K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on Dimension Capital Management's 13F filing for Q1 2024, filed 13 May 2024.